The team submits PA requests through the correct payer portal, tracks status daily, and escalates urgent cases
Tirzepatide (Mounjaro) dual GIP/GLP-1 receptor agonist) 3,4 3,4 Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that produces superior weight loss compared with selective GLP-1 receptor agonists, through: Enhanced appetite suppression via dual receptor activation
Learn more about the best protein sources to try and which protein powders dietitians recommend
Provider supervision matters because a safe plan should include health-history review, medication review, lab evaluation when appropriate, nutrition support, hydration guidance, side-effect monitoring, and follow-up care
A 2003 study by Khavinson's team lengthened telomeres in human cells, and in 2025 an independent group at Brunel University London reported dose-dependent telomere extension in normal human cells
Frequency depends on your health goals and current B12 levels